292 723

Cited 0 times in

Dose-response relationship between radiation dose and loco-regional control in patients with stage II-III esophageal cancer treated with definitive chemoradiotherapy

DC Field Value Language
dc.contributor.author김현주-
dc.date.accessioned2019-06-18T01:37:25Z-
dc.date.available2019-06-18T01:37:25Z-
dc.date.issued2017-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/169701-
dc.description의학과/석사-
dc.description.abstractPurpose: The correlation between radiation dose and loco-regional control (LRC) was evaluated in patients with stage II–III esophageal cancer treated with definitive concurrent chemoradiotherapy (CRT). Materials and Methods: Medical records of 236 stage II–III esophageal cancer patients treated with definitive CRT at Yonsei Cancer Center between 1994 and 2013 were retrospectively reviewed. Among these, 120 received a radiation dose of <60 Gy (standard-dose group), while 116 received ≥60 Gy (high-dose group). The median doses of radiation in the standard- and high-dose groups were 50.4 and 63 Gy, respectively. Concurrent 5-fluorouracil/cisplatin chemotherapy was administered to most patients. 2 Results: There were no differences in patient characteristics between the two groups except for high Karnofsky performance status and lower-thoracic lesions being more prevalent in the standard-dose group. The median progression-free survival (PFS) and overall survival (OS) times were 13.2 and 26.2 months, respectively. Patients in the high-dose group had significantly better 2-year LRC (69.1% vs. 50.3%, P = 0.002), median PFS (16.7 vs. 11.7 months, P = 0.029), and median OS (35.1 vs. 22.3 months, P = 0.043). Additionally, LRC exhibited a dose-response relationship and the complete response rate was significantly higher in the high-dose group (P = 0.006). There were no significant differences in treatment-related toxicities between the groups. Conclusion: A higher radiation dose (>60 Gy) is associated with increased LRC, PFS, and OS in patients with stage II–III esophageal cancer treated with definitive CRT.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.publisherGraduate School, Yonsei University-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleDose-response relationship between radiation dose and loco-regional control in patients with stage II-III esophageal cancer treated with definitive chemoradiotherapy-
dc.title.alternative근치적 항암화학방사선 병용요법으로 치료받은 2-3기 식도암 환자에서 방사선량과 국소제어율간의 선량-반응관계-
dc.typeThesis-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Radiation Oncology (방사선종양학교실)-
dc.contributor.departmentDept. of Radiation Oncology (방사선종양학교실)-
dc.contributor.localIdA04551-
dc.subject.keywordEsophageal neoplasms-
dc.subject.keywordChemoradiotherapy-
dc.subject.keywordDose-response relationship-
dc.description.degree석사-
dc.contributor.alternativeNameKim, Hyun Ju-
dc.contributor.affiliatedAuthor김현주-
dc.type.localThesis-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 3. Dissertation

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.